← Back to context

Comment by seamossfet

14 days ago

The Drug App - a CAD for drug design.

It's focused on structural analysis right now, but the goal is to allow for biologists, crystallographers, chemists, etc to quickly analyze large samples of structural data for patterns and find where those patterns break down.

Our goal is to make it a platform to analyze the output of various papers, tools, and structures to build a single unified biological model of your druggable target. For example, what if your alphafold output disagrees with pre-existing literature? If Diffdock says your candidate can bind to a pocket on a protein that hasn't been validated yet, what's the implications of that on the underlying biological mechanism?

Biology is extremely complicated, so scientists create simplified lenses of the world to make sense of things. Biologists are looking at different things than crystallographers, crystallographers are looking at different things than computational chemists, etc, etc.

Finding disagreements in these simplified lenses early can save a lot of money before things move to lab experiments.